Global Pharmaceuticals & Biotech Undervalued based on future growth

Grifols

Market Cap: €6.0b

Engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and internationally.

Alkermes

Market Cap: US$4.7b

A biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.

ACADIA Pharmaceuticals

Market Cap: US$3.8b

A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

Corcept Therapeutics

Market Cap: US$3.6b

A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

China Resources Pharmaceutical Group

Market Cap: HK$28.2b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

Hypera

Market Cap: R$13.9b

Operates as a pharmaceutical company in Brazil.

Nanjing King-Friend Biochemical PharmaceuticalLtd

Market Cap: CN¥15.9b

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.

BioCryst Pharmaceuticals

Market Cap: US$2.2b

A biotechnology company, developing and commercializing medicines for hereditary angioedema (HAE) and other rare diseases.

Lotus Pharmaceutical

Market Cap: NT$68.0b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Bausch Health Companies

Market Cap: US$2.0b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Bora Pharmaceuticals

Market Cap: NT$57.1b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Organon

Market Cap: US$1.7b

Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

Square Pharmaceuticals

Market Cap: ৳191.2b

Manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally.

L&C BIOLTD

Market Cap: ₩2.1t

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine.

KPC PharmaceuticalsInc

Market Cap: CN¥9.2b

A pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

Luye Pharma Group

Market Cap: HK$9.9b

Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.

Alvotech

Market Cap: US$1.3b

Through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.

Collegium Pharmaceutical

Market Cap: US$1.2b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

Genomma Lab Internacional. de

Market Cap: Mex$17.3b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

Strides Pharma Science

Market Cap: ₹80.5b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Basilea Pharmaceutica

Market Cap: CHF 663.7m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Gerresheimer

Market Cap: €683.9m

Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.

Tong Ren Tang Technologies

Market Cap: HK$5.5b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Zeria Pharmaceutical

Market Cap: JP¥94.8b

Manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally.

Zevra Therapeutics

Market Cap: US$535.4m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

CorMedix

Market Cap: US$518.6m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Newron Pharmaceuticals

Market Cap: CHF 370.8m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Blau Farmacêutica

Market Cap: R$2.4b

A pharmaceutical company provides drug products in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States.

Dong-A Socio Holdings

Market Cap: ₩693.1b

Engages in the pharmaceutical business in South Korea.

Beximco Pharmaceuticals

Market Cap: ৳51.5b

Manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

Renata

Market Cap: ৳49.3b

Manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.

SIGA Technologies

Market Cap: US$401.0m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

GlaxoSmithKline Pakistan

Market Cap: PK₨101.6b

Operates as a biopharma company in Pakistan.

Clinuvel Pharmaceuticals

Market Cap: AU$506.0m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

JBM (Healthcare)

Market Cap: HK$2.3b

An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.

Essex Bio-Technology

Market Cap: HK$2.2b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.